Animal Zoonotic Related Diseases (2024)

Continuing Education Activity

Zoonotic diseases are increasingly important due to the interaction between humans and animal habitats. To avoid the high morbidity and mortality associated with these diseases, they must be promptly diagnosed and treated. This activity reviews the evaluation and treatment of zoonotic diseases and highlights the role of the interprofessional team in evaluating and treating patients in a timely fashion.

Objectives:

Review the risk factors for developing zoonotic diseases.
Summarize the epidemiology of the most important zoonotic diseases.
Outline the typical presentation of patients with zoonotic diseases.
Describe how an interprofessional team can coordinate care to obtain the best outcomes in a patient with a zoonotic disease.

Access free multiple choice questions on this topic.

Introduction

Animals play a valuable role in our lives as food, livestock, hunting, travel, sports, zoo, fairs, research, pets, and guide-pets.[1][2]Zoonotic diseases encompass more than 200 diseases that are transmitted to humans from an animal origin, where humans are usually accidental hosts. They were first recognized by Rudolf Virchow and Osler in the 1800s. The word “zoonosis” consists of 2 parts; “Zoo” means an animal, and “nosis” means sickness.

Etiology

One important reason for the spread of zoonoses is anthropogenic changes in animal biodiversity, leading to the predominance of bats and rodents in the environment. Other important factors include the rapid increase in the human population, the intersection with animal habitats, deforestation practices, suburbs formation, bushmeat industry (worth $15 billion annually in the U.S.), effects of global warming, free travel and open trade, adoption of exotic pets, consumption of edible insects, genetic mutations, asymptomatic animal carriers especially poultry, and the spill-over effect, i.e., the transmission of a pathogen from one host species to another new one, crossing the biological barriers, due to the high infection prevalence in the former.[3][4][5][6][7][8][9][10][11]

Children below 5 years of age, the elderly above 65, immunocompromised persons, and pregnant women are all vulnerable populations at the highest risk for zoonotic diseases.[12][13]Those with specific occupations like veterinarians, butchers, hunters, etc., are by nature at a higher risk of acquiring zoonotic diseases. It is interesting to note that new and young pets carry a higher risk of transmitting zoonotic disease than old adult ones.[14]

More than 2200 species of rodents exist, making them the most abundant zoonotic hosts. Almost 1100 species of bats act as a reservoir for many serious zoonoses like Nipah, Hendra, Menangle, Corona, Ebola, and Marburg viruses.[15][16]Carnivores make up the greatest fraction of carrier zoonotic hosts, especially for bacteria and viruses.[17]

Classification of zoonotic diseases can be done according to pathogen type, transmission, animal source, affected human organ system, or ecosystem.

Table 1. List of the most common pathogens causing zoonoses[18][19][20][21][22][23][24][25][26]

Table

Bacteria (42%) Viruses (22%)

(*: Avian: H5N1, H7N9, H9N2. Swine: H1N1, H1N2, H3N2, H7N2. Spanish Flu is H1N1 from bats)

(SARS: Severe Acute Respiratory Syndrome, MERS: Middle East respiratory syndrome, WNV: West Nile virus, EEE: Eastern Equine encephalitis, WEE: Western Equine encephalitis, VEE: Venezuela Equine encephalitis, LCMV: Lymphocytic Chorio-Meningitis virus, HIV: human immunodeficiency virus, vCJD: Variant Creutzfeldt-Jakob disease)

Epidemiology

In the U.S., 68% of households have pets. There are 45 million dog owners and 77 million cat owners.

Zoonoses constitute 61% of infectious diseases, 75% of emerging infectious diseases, and 80% potential bioterrorism pathogens.[27][28]

Per the last report by the Centers for Disease Control and Prevention (CDC), Department of the Interior, and U.S. Department of Agriculture, the eight most important zoonoses in the U.S., based on their pandemic potential, severity, economic impact, local potential, and bioterrorism risk, are influenza, salmonella, West Nile virus, plague, coronaviruses, rabies, brucella, and Lyme disease.

Important statistics about each zoonotic disease:

Influenza has caused several outbreaks in different countries in the last few decades, especially H1N1 swine flu in 2009& H5N1 avian flu since 2003.[29]

Salmonella is the most common cause of zoonotic outbreaks in the USA in the last decade, per the CDC.

WNV is the most common mosquito-borne zoonosis in the USA. It is estimated that there are 70 unreported cases for each reported case of the disease.

Plague is endemic in western states - California, Arizona, Colorado, and New Mexico. The incidence rate is 1-17 cases/year.

Coronaviruses: SARS caused >8000 infections in 2003 in Southeast Asia. MERS has infected >2000 people since 2012.[30]SARS-CoV-2 has infected around 120 million people since 2019.

Rabies: There are around 40,000 exposures reported per year in the U.S., which costs the health system $225 million to $500 million for post-exposure prophylaxis alone. There were only nine established rabies in humans from 2008 to 2019 due to stray animal control, rabies vaccine, and oral rabies vaccine baiting programs.[31]

Brucella: Almost all cases in the U.S. are related to immigrants, imported animals, or unpasteurized milk. There are around 100 reported cases annually.

Lyme disease is the most common vector-borne disease in the U.S., with 20,000 cases/year; 95% of the cases belong to 12 states in the Northeast & Mid-Atlantic U.S.

Leptospira is the most common zoonotic disease worldwide. Most cases in the U.S. are seen in Hawaii in farmers, veterinarians, and surfers.

RMSF is the most common rickettsial disease in the U.S., with 600to 1200 cases/year, mainly in the Southeastern and South Central U.S., especially North Carolina and Arkansas.

Hanta: The Sin Nombre & Seoul strains are found in the U.S., mainly Utah, Colorado, Arizona, and New Mexico.

Babesiosis: B.microti is seen in the Northeastern states, and B.divergens is seen in Europe.

Toxoplasma: 30% of the US population are asymptomatic carriers.[32]

Giardia is one of the most common gastrointestinal parasites in the U.S.

Pathophysiology

Modes of Transmission:

Direct Contact (touch, scratch, licking)
Indirect Contact (fomites, soil, water)
Animal Bites cause >4.7 million cases, 0.3 million ED visits, 10,000 hospitalizations, and 20 deaths in the U.S. per year, most commonly from dogs (80-90%) and cats (5% to 15%).[33][34]
Vector-borne (ticks, mosquitoes, lice, fleas, mites)
Inhalation (droplet, aerosols from products of animal conception and feces)
Ingestion (vegetables, meats, eggs, milk, water)

According to ND Wolfe’s paper in Nature 2007, pathogens go through five stages to transmit infections from animals to man:[35]

Stage 1: pathogens existing among animals only
Stage 2: limited infections from animals to some humans
See Also
New international expert panel to address the emergence and spread of zoonotic diseases One Health is critical to addressing zoonotic public health threats and environmental issues
Stage 3: limited outbreak level
Stage 4: long outbreak level where human to human transmission can occur
Stage 5: the pathogen can become an exclusively human pathogen with free transmission potential

Table 2. Mode of transmission and animal source of important zoonotic diseases[36][37][38][39][40][41][42][43]

Table

Organism Mode of Transmission

(*Deer only act as an alternative reservoir for the Ixodes scapularis itself; hence the name “deer tick.”)

History and Physical

A detailed history must be obtained from patients with special attention to travel history, location of residence, occupation, vaccination status, hobbies, pets, other animal exposure, and diet. Immunosuppressed patients have more aggressive diseases than the general population.

Table 3. The clinical picture of important zoonotic diseases classified by affected organ systems[44][45][13]

Table

Infection Clinical Picture

(WNV: West Nile Virus, vCJD: Variant Creutzfeldt-Jakob Disease, CLM: Cutaneous larva migrans, RMSF: Rocky Mountain spotted fever)

Evaluation

It is important to have public health data available at both national and local levels as a valuable reference while considering a possible zoonotic infection.

CBC: lymphocytosis is seen in influenza and brucellosis, lymphopenia is seen with COVID-19, thrombocytopenia in babesiosis, Coxiella, RMSF and leptospirosis, eosinophilia in trichinellosis.
Peripheral blood smear: maltese cross appearance is seen in babesiosis
Kidney function tests, liver function tests
Imaging as a chest x-ray
CSF testing: to look for WNV, vCJD, rabies
EEG: to look for waveform abnormalities as seen with WNV and vCJD
Cultures (blood, sputum, tissue): to detect plague, anthrax, salmonella, and Capnocytophaga
Serology: to detect Lyme disease, WNV, psittacosis, Bartonella.
PCR / RT-PCR: to detect influenza, COVID-19, WNV, psittacosis
Matrix-assisted laser desorption/ionization (MALDI-TOF): as in anthrax
Animal autopsy: for rabies

Treatment / Management

Treatment varies with the pathogen.

Influenza is usually self-limited. Otherwise, treatment regimens include Oseltamivir or Baloxavir.

Salmonella is usually managed supportively. Quinolones, azithromycin, trimethoprim-sulfamethoxazole, and ceftriaxone are all available options.

Plague is classically managed with aminoglycosides, tetracyclines, and quinolones as a last resort.

A combination treats brucella of doxycycline and an aminoglycoside or rifampicin in non-pregnant adults.

COVID-19 is currently managed per the latest guidelines on remdesivir, dexamethasone, and supportive measures.

Lyme disease is treated by doxycycline or a beta-lactam depending on the stage and presentation.

RMSF is managed by doxycycline as the drug of choice.

Psittacosis is recommended to be treated by tetracyclines, with azithromycin as an alternative.

Coxiella is managed with doxycycline, with the addition of hydroxychloroquine in vascular complications.

A combination lately treats anthrax of quinolones, carbapenems, linezolid, and immunoglobulin for systemic infections. Quinolones or doxycycline are utilized for limited cutaneous infections.

Dermatophytes: Topical or systemic antifungals in addition to animal treatment as well.

WNV, Rabies, and Rift Valley Fever are managed through supportive treatment only.

Ebola is suggested to be managed with the new agents atoltivimab, maftivimab, odesivimab (REGN-EB3), and ansuvimab.

Government strategies to decrease zoonoses include ensuring safe food products of animal origin, scaling back economic development in the wild, the shift from reactionary to pre-emptive approach on zoonoses, and availability of travel medicine guidelines.[46]

The ‘One Health 2006 Initiative’ focuses on the collaboration between human (physicians, nurses, and public health practitioners), animal (veterinarians), plants (agricultural workers), and environmental (ecologists, and wildlife experts) sectors to achieve optimal health since they are all interconnected.[47]This was started after the 1999 WNV outbreak in New York City, where one-sided prevention was shown to be inefficient. One Health Zoonotic Diseases Prioritization (OHZDP) workshops aim to prioritize zoonoses, develop action plans, maintain equative collaborative sectors’ input, and appropriately focus resources.[48]

Differential Diagnosis

Zoonotic diseases must not be confused with other groups of diseases, including:[49]

Zooanthroponosis (reverse-zoonosis), which are infections transmitted from humans to animals, such as tuberculosis

Amphixenosis, which are infections transmitted in both directions from animals to humans and vice versa, such as staphylococcal infections

Euzoonosis, where humans act as an obligatory host in the pathogen’s life cycle, such as Taenia solium and Taeniasaginata

Zoonoses also have to be differentiated from other common infections of similar presentations, and one should not be completely misled by a certain animal exposure in the context. Similarly, contact with animals, insects, and the wilderness, can cause other non-infectious pathologies like allergic reactions, which have to be considered in the differential diagnosis.

Prognosis

Prognosis varies with the pathogen:

Influenza: Case fatality is up to 60% in Avian flu and less than 1% in Swine flu.

WNV: Case fatality is 6%.

Plague: Case fatality is 13% with treatment and more than 80% without treatment.

The fatality of SARS is 9.6%, MERS is 35%, andSARS-CoV-2 is 3% to 6%, resulting in more than 2.5 million deaths.[50]

Rabies: Globally causes more deaths than any other zoonosis at 30,000 to 70,000 annually.[51][52]

Brucella: Case fatality is 2% to 5% if untreated.

Anthrax: Case fatality is more than 80% from inhalation anthrax.

Coxiella: Case fatality is 2% in acute and 20% in chronic disease.

Ebola: Case fatality is around 50%.

RMSF: Case fatality is 22% without treatment and 6% with treatment.[53]

Low mortality zoonoses (less than 1%) include salmonellosis, Lyme disease, rift valley fever, and psittacosis.

Complications

Known complications of the important zoonotic diseases are as follows:[54]

Influenza: Secondary pneumonia, myositis, myocarditis, encephalitis, and Guillain-Barre syndrome

Salmonella: Bacteremia, osteomyelitis, endocarditis, and mycotic aneurysms

WNV: Meningitis, encephalitis, chorioretinitis, fatal hemorrhagic fever, hepatitis, and myocarditis

Plague: Meningitis, shock, DIC, and multiorgan failure

COVID-19: Respiratory failure, arrhythmias, acute coronary syndrome, shock, thromboembolic manifestations, acute kidney injury, and systemic inflammation

Rabies: Seizures, coma, respiratory failure, arrhythmias, and myocarditis

Brucella: Arthritis, meningitis, pneumonia, orchitis, abortion, uveitis, and endocarditis

Lyme: Bannwarth syndrome, facial palsy, meningitis, atrioventricular blocks, acrodermatitis chronica atrophica, and post-Lyme syndrome

The economic impact of zoonotic diseases is a major concern, mostly due to its notorious effect on international travel, tourism, and trade, especially about animals and animal products. For example, the avian flu 2015 outbreak has caused a $3.3 billion loss to the U.S. economy.

Many zoonotic diseases also have the potential for causing severe complex diseases in transplant patients and other immunocompromised individuals. Also, many of them can be utilized as bioterrorism weapons.

Deterrence and Patient Education

Veterinarian visits should be scheduled regularly and for any pet illness. Catclaw clipping is recommended to avoid scratches. Owners should avoid feeding their pets any raw meat or eggs.[12]Reptile pets are strongly recommended to be kept away from children less than 5 years old and away from kitchens.

Proper tetanus immunization with or without immunoglobulins for bites is to be followed per guidelines. Animal vaccination for rabies, leptospira, and brucella, is also an essential practice. WNV vaccination is essential for horses. New vaccines are in process for several zoonoses, such as the new influenza A strains and plague.

Tick and flea control can be done by advising the public to wear light-colored clothes, long sleeves, tucking-in pants, using DEET spray, conducting body checks for early removal of ticks, and inspecting pets for ticks after going into wooded areas. Leaf debris removal and importation of fire ants to eat tick eggs can be done by environmental authorities to control the breeding of ticks and fleas.[55]Measures should be taken to avoid mosquito bites.

Public awareness programs to encourage handwashing is important. Awareness should be raised among healthcare workers about emerging infectious diseases and the available resources for the same. Continuous surveillance, disease reporting, and mapping programs for zoonotic diseases are ongoing in humans and animals.

Enhancing Healthcare Team Outcomes

Medical providers, including physicians, nurse practitioners, and physician assistants, must keep in mind the possibility of certain zoonotic diseases, depending on the geographical location, travel history, and exposure to certain animals.[56]The COVID-19 pandemic typifies the importance of the human-animal interface and the One World One Health paradigm. Appreciation of the effect of human behavior as a coordinated interprofessional team, and the potential disruption of natural barriers to species jumping infections can help prevent a pathogenic emergency, which may lead to epidemics or pandemics.

Review Questions

References

1.: Parslow RA, Jorm AF. Pet ownership and risk factors for cardiovascular disease: another look. Med J Aust. 2003 Nov 03;179(9):466-8. [PubMed: 14583076]
2.: National Association of State Public Health Veterinarians, Inc. (NASPHV); Centers for Disease Control and Prevention (CDC); Council of State and Territorial Epidemiologists; American Veterinary Medical Association. Compendium of measures to prevent disease associated with animals in public settings, 2007: National Association of State Public Health Veterinarians, Inc. (NASPHV). MMWR Recomm Rep. 2007 Jul 06;56(RR-5):1-14. [PubMed: 17615524]
3.: Chomel BB, Belotto A, Meslin FX. Wildlife, exotic pets, and emerging zoonoses. Emerg Infect Dis. 2007 Jan;13(1):6-11. [PMC free article: PMC2725831] [PubMed: 17370509]
4.: Field H, Young P, Yob JM, Mills J, Hall L, Mackenzie J. The natural history of Hendra and Nipah viruses. Microbes Infect. 2001 Apr;3(4):307-14. [PubMed: 11334748]
5.: Cutler SJ, f*cks AR, van der Poel WH. Public health threat of new, reemerging, and neglected zoonoses in the industrialized world. Emerg Infect Dis. 2010 Jan;16(1):1-7. [PMC free article: PMC2874344] [PubMed: 20031035]
6.: Bengis RG, Leighton FA, Fischer JR, Artois M, Mörner T, Tate CM. The role of wildlife in emerging and re-emerging zoonoses. Rev Sci Tech. 2004 Aug;23(2):497-511. [PubMed: 15702716]
7.: Williams ES, Yuill T, Artois M, Fischer J, Haigh SA. Emerging infectious diseases in wildlife. Rev Sci Tech. 2002 Apr;21(1):139-57. [PubMed: 11974625]
8.: Ahmed S, Dávila JD, Allen A, Haklay MM, Tacoli C, Fèvre EM. Does urbanization make emergence of zoonosis more likely? Evidence, myths and gaps. Environ Urban. 2019 Oct;31(2):443-460. [PMC free article: PMC6798138] [PubMed: 31656370]
9.: Allen T, Murray KA, Zambrana-Torrelio C, Morse SS, Rondinini C, Di Marco M, Breit N, Olival KJ, Daszak P. Global hotspots and correlates of emerging zoonotic diseases. Nat Commun. 2017 Oct 24;8(1):1124. [PMC free article: PMC5654761] [PubMed: 29066781]
10.: Johnson PT, Thieltges DW. Diversity, decoys and the dilution effect: how ecological communities affect disease risk. J Exp Biol. 2010 Mar 15;213(6):961-70. [PubMed: 20190121]
11.: Silva J, Leite D, Fernandes M, Mena C, Gibbs PA, Teixeira P. Campylobacter spp. as a Foodborne Pathogen: A Review. Front Microbiol. 2011;2:200. [PMC free article: PMC3180643] [PubMed: 21991264]
12.: Trevejo RT, Barr MC, Robinson RA. Important emerging bacterial zoonotic infections affecting the immunocompromised. Vet Res. 2005 May-Jun;36(3):493-506. [PubMed: 15845236]
13.: Mrzljak A, Novak R, Pandak N, Tabain I, Franusic L, Barbic L, Bogdanic M, Savic V, Mikulic D, Pavicic-Saric J, Stevanovic V, Vilibic-Cavlek T. Emerging and neglected zoonoses in transplant population. World J Transplant. 2020 Mar 31;10(3):47-63. [PMC free article: PMC7109593] [PubMed: 32257849]
14.: Robinson RA, Pugh RN. Dogs, zoonoses and immunosuppression. J R Soc Promot Health. 2002 Jun;122(2):95-8. [PubMed: 12134775]
15.: Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, Délicat A, Paweska JT, Gonzalez JP, Swanepoel R. Fruit bats as reservoirs of Ebola virus. Nature. 2005 Dec 01;438(7068):575-6. [PubMed: 16319873]
16.: Towner JS, Pourrut X, Albariño CG, Nkogue CN, Bird BH, Grard G, Ksiazek TG, Gonzalez JP, Nichol ST, Leroy EM. Marburg virus infection detected in a common African bat. PLoS One. 2007 Aug 22;2(8):e764. [PMC free article: PMC1942080] [PubMed: 17712412]
17.: Han BA, Kramer AM, Drake JM. Global Patterns of Zoonotic Disease in Mammals. Trends Parasitol. 2016 Jul;32(7):565-577. [PMC free article: PMC4921293] [PubMed: 27316904]
18.: McDaniel CJ, Cardwell DM, Moeller RB, Gray GC. Humans and cattle: a review of bovine zoonoses. Vector Borne Zoonotic Dis. 2014 Jan;14(1):1-19. [PMC free article: PMC3880910] [PubMed: 24341911]
19.: Parish LC, Schwartzman RM. Zoonoses of dermatological interest. Semin Dermatol. 1993 Mar;12(1):57-64. [PubMed: 8476735]
20.: Chomel BB. Zoonoses of house pets other than dogs, cats and birds. Pediatr Infect Dis J. 1992 Jun;11(6):479-87. [PubMed: 1608686]
21.: Boseret G, Losson B, Mainil JG, Thiry E, Saegerman C. Zoonoses in pet birds: review and perspectives. Vet Res. 2013 May 20;44(1):36. [PMC free article: PMC3668993] [PubMed: 23687940]
22.: Decostere A, Hermans K, Haesebrouck F. Piscine mycobacteriosis: a literature review covering the agent and the disease it causes in fish and humans. Vet Microbiol. 2004 Apr 19;99(3-4):159-66. [PubMed: 15066718]
23.: Guardia SN, Sepp H, Scholten T, Morava-Protzner I. Pentastomiasis in Canada. Arch Pathol Lab Med. 1991 May;115(5):515-7. [PubMed: 2021321]
24.: Huff JL, Barry PA. B-virus (Cercopithecine herpesvirus 1) infection in humans and macaques: potential for zoonotic disease. Emerg Infect Dis. 2003 Feb;9(2):246-50. [PMC free article: PMC2901951] [PubMed: 12603998]
25.: Blake LA, West BC, Lary CH, Todd JR. Environmental nonhuman sources of leprosy. Rev Infect Dis. 1987 May-Jun;9(3):562-77. [PubMed: 3299637]
26.: Oxford JS, Lambkin R, Sefton A, Daniels R, Elliot A, Brown R, Gill D. A hypothesis: the conjunction of soldiers, gas, pigs, ducks, geese and horses in northern France during the Great War provided the conditions for the emergence of the "Spanish" influenza pandemic of 1918-1919. Vaccine. 2005 Jan 04;23(7):940-5. [PubMed: 15603896]
27.: Taylor LH, Latham SM, Woolhouse ME. Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci. 2001 Jul 29;356(1411):983-9. [PMC free article: PMC1088493] [PubMed: 11516376]
28.: Vorou RM, Papavassiliou VG, Tsiodras S. Emerging zoonoses and vector-borne infections affecting humans in Europe. Epidemiol Infect. 2007 Nov;135(8):1231-47. [PMC free article: PMC2870710] [PubMed: 17445320]
29.: Shrestha SS, Swerdlow DL, Borse RH, Prabhu VS, Finelli L, Atkins CY, Owusu-Edusei K, Bell B, Mead PS, Biggerstaff M, Brammer L, Davidson H, Jernigan D, Jhung MA, Kamimoto LA, Merlin TL, Nowell M, Redd SC, Reed C, Schuchat A, Meltzer MI. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis. 2011 Jan 01;52 Suppl 1:S75-82. [PubMed: 21342903]
30.: Nassar MS, Bakhrebah MA, Meo SA, Alsuabeyl MS, Zaher WA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics. Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):4956-4961. [PubMed: 30070331]
31.: Murphy J, Sifri CD, Pruitt R, Hornberger M, Bonds D, Blanton J, Ellison J, Cagnina RE, Enfield KB, Shiferaw M, Gigante C, Condori E, Gruszynski K, Wallace RM. Human Rabies - Virginia, 2017. MMWR Morb Mortal Wkly Rep. 2019 Jan 04;67(5152):1410-1414. [PMC free article: PMC6334827] [PubMed: 30605446]
32.: Remington JS. Toxoplasmosis in the adult. Bull N Y Acad Med. 1974 Feb;50(2):211-27. [PMC free article: PMC1749356] [PubMed: 4592097]
33.: Goldstein EJ. Bite wounds and infection. Clin Infect Dis. 1992 Mar;14(3):633-8. [PubMed: 1562653]
34.: Centers for Disease Control and Prevention (CDC). Nonfatal dog bite-related injuries treated in hospital emergency departments--United States, 2001. MMWR Morb Mortal Wkly Rep. 2003 Jul 04;52(26):605-10. [PubMed: 12844076]
35.: Wolfe ND, Dunavan CP, Diamond J. Origins of major human infectious diseases. Nature. 2007 May 17;447(7142):279-83. [PMC free article: PMC7095142] [PubMed: 17507975]
36.: Buhariwalla F, Cann B, Marrie TJ. A dog-related outbreak of Q fever. Clin Infect Dis. 1996 Oct;23(4):753-5. [PubMed: 8909839]
37.: Talan DA, Citron DM, Abrahamian FM, Moran GJ, Goldstein EJ. Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. N Engl J Med. 1999 Jan 14;340(2):85-92. [PubMed: 9887159]
38.: Baxby D, Bennett M, Getty B. Human cowpox 1969-93: a review based on 54 cases. Br J Dermatol. 1994 Nov;131(5):598-607. [PubMed: 7999588]
39.: de Lima Barros MB, de Oliveira Schubach A, Galhardo MC, Schubach TM, dos Reis RS, Conceição MJ, do Valle AC. Sporotrichosis with widespread cutaneous lesions: report of 24 cases related to transmission by domestic cats in Rio de Janeiro, Brazil. Int J Dermatol. 2003 Sep;42(9):677-81. [PubMed: 12956676]
40.: Traub R, Wade S, Read C, Thompson A, Mohammed H. Molecular characterization of potentially zoonotic isolates of Giardia duodenalis in horses. Vet Parasitol. 2005 Jun 30;130(3-4):317-21. [PubMed: 15925726]
41.: Marrie TJ. Coxiella burnetii pneumonia. Eur Respir J. 2003 Apr;21(4):713-9. [PubMed: 12762362]
42.: Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, Sun B, Hull HF., Advisory Committee on Immunization Practices Centers for Disease Control and Prevention (CDC). Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2008 May 23;57(RR-3):1-28. [PubMed: 18496505]
43.: White MH, Armstrong D. Cryptococcosis. Infect Dis Clin North Am. 1994 Jun;8(2):383-98. [PubMed: 8089466]
44.: Rahman MT, Sobur MA, Islam MS, Ievy S, Hossain MJ, El Zowalaty ME, Rahman AT, Ashour HM. Zoonotic Diseases: Etiology, Impact, and Control. Microorganisms. 2020 Sep 12;8(9) [PMC free article: PMC7563794] [PubMed: 32932606]
45.: Day MJ. Pet-Related Infections. Am Fam Physician. 2016 Nov 15;94(10):794-802. [PubMed: 27929279]
46.: Santana C. COVID-19, other zoonotic diseases and wildlife conservation. Hist Philos Life Sci. 2020 Oct 08;42(4):45. [PMC free article: PMC7542570] [PubMed: 33030629]
47.: Kelly TR, Karesh WB, Johnson CK, Gilardi KV, Anthony SJ, Goldstein T, Olson SH, Machalaba C, PREDICT Consortium. Mazet JA. One Health proof of concept: Bringing a transdisciplinary approach to surveillance for zoonotic viruses at the human-wild animal interface. Prev Vet Med. 2017 Feb 01;137(Pt B):112-118. [PMC free article: PMC7132382] [PubMed: 28034593]
48.: Yasobant S, Saxena D, Bruchhausen W, Memon FZ, Falkenberg T. Multi-sectoral prioritization of zoonotic diseases: One health perspective from Ahmedabad, India. PLoS One. 2019;14(7):e0220152. [PMC free article: PMC6667134] [PubMed: 31361782]
49.: Hubálek Z. Emerging human infectious diseases: anthroponoses, zoonoses, and sapronoses. Emerg Infect Dis. 2003 Mar;9(3):403-4. [PMC free article: PMC2958532] [PubMed: 12643844]
50.: Lu L, Zhong W, Bian Z, Li Z, Zhang K, Liang B, Zhong Y, Hu M, Lin L, Liu J, Lin X, Huang Y, Jiang J, Yang X, Zhang X, Huang Z. A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis. J Infect. 2020 Oct;81(4):e18-e25. [PMC free article: PMC7334925] [PubMed: 32634459]
51.: f*cks AR, Banyard AC, Horton DL, Johnson N, McElhinney LM, Jackson AC. Current status of rabies and prospects for elimination. Lancet. 2014 Oct 11;384(9951):1389-99. [PMC free article: PMC7159301] [PubMed: 24828901]
52.: Krebs JW, Mandel EJ, Swerdlow DL, Rupprecht CE. Rabies surveillance in the United States during 2003. J Am Vet Med Assoc. 2004 Dec 15;225(12):1837-49. [PubMed: 15643834]
53.: Biggs HM, Behravesh CB, Bradley KK, Dahlgren FS, Drexler NA, Dumler JS, Folk SM, Kato CY, Lash RR, Levin ML, Massung RF, Nadelman RB, Nicholson WL, Paddock CD, Pritt BS, Traeger MS. Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States. MMWR Recomm Rep. 2016 May 13;65(2):1-44. [PubMed: 27172113]
54.: Meslin FX. Impact of zoonoses on human health. Vet Ital. 2006 Oct-Dec;42(4):369-79. [PubMed: 20429071]
55.: Reynolds HH, Elston DM. What's eating you? lone star tick (Amblyomma americanum). Cutis. 2017 Feb;99(2):111-114. [PubMed: 28319627]
56.: Coyle AL. Elizabethkingia anophelis: Exploring the outbreak of disease in the Midwest. Nursing. 2017 Mar;47(3):61-63. [PubMed: 28225402]

: Disclosure: Mina Said declares no relevant financial relationships with ineligible companies.
: Disclosure: Ekta Tirthani declares no relevant financial relationships with ineligible companies.
: Disclosure: Emil Lesho declares no relevant financial relationships with ineligible companies.